NCT04464967 2021-05-12Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersNKGen Biotech, Inc.Phase 1/2 Withdrawn
NCT02713984 2020-03-19A Clinical Research of CAR T Cells Targeting HER2 Positive CancerSouthwest Hospital, ChinaPhase 1/2 Withdrawn